Back to News & Media

Select Media Coverage

April 11, 2024

Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

Read Article

February 22, 2024

Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C

Read Article

February 22, 2024

San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial

Read Article
Frontier Medicines Logo

South San Francisco Office 

151 Oyster Point Blvd., 2nd Floor 
South San Francisco, CA 94080

Boston Office 

451 D St., Suite 207 
Boston, MA 02210

© 2024 Frontier Medicines

Frontier Medicines Logo

South San Francisco Office
151 Oyster Point Blvd., 2nd Floor
South San Francisco, CA 94080

Boston Office 
451 D St., Suite 207 
Boston, MA 02210

© 2024 Frontier Medicines